BioSpace News Archive

Cingulate Inc. announced that it will be attending DCAT Week March 18-21, 2024, in Midtown Manhattan.

Enterome announced that data on its novel OncoMimics™ approach to cancer immunotherapy will be presented in a poster at the upcoming American Association of Cancer Research Annual Meeting, taking place April 5-10 in San Diego, California.

Pharvaris announced the acceptance of abstracts for presentation at two upcoming congresses: the 3rd National Congress of the Italian Network for Hereditary and Acquired Angioedema, to be held from March 14-16, 2024, in Milan, Italy, and the 2024 HAE International Regional Conference Americas, to be held from March 15-17, 2024, in Panama City, Panama.

ADC Therapeutics SA announced that it will host a conference call and live webcast on Wednesday, March 13, 2024, at 8:30 a.m. ET to report financial results for the fourth quarter and year ended December 31, 2023, and provide business updates.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that its management expects to participate in the following investor conferences in March.

Kraig Biocraft Laboratories, Inc., announces that it is preparing a second business investment application in Vietnam as part of the planned expansion of its business operations.

In 2023, the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research approved 55 new drugs, 17 of which were biopharmaceuticals.

InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the treatment of carotid artery disease and prevention of stroke, announced financial and operating results for the fourth quarter and full-year ended December 31, 2023.

iTeos Therapeutics, Inc. announced the appointment of Jill DeSimone to its Board of Directors, effective March 7, 2024, where she will serve on the Company’s audit committee.

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company focused on the development of Superkines, announced that two posters will be presented at the American Association for Cancer Research Annual Meeting 2024, taking place in San Diego, CA from April 5-10, 2024.